GSK3 inhibitors

Cells treated with the compound (right) showed reduced infection from the Omicron variant compared to untreated cells (left). (Photo credit: Dr. Selvarani Vimalanathan, Molecular Biomedicine)
A compound shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold